SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-007982
Filing Date
2023-11-13
Accepted
2023-11-13 16:01:31
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sonoma_i10q-093023.htm   iXBRL 10-Q 700394
2 BOULDER LEASE AGREEMENT BETWEEN THE COMPANY AND WESTLAND DEVELOPMENT SERVICES, I sonoma_ex1020.htm EX-10.20 158668
3 FIRST AMENDMENT TO THE LEASE BETWEEN THE COMPANY AND WESTLAND DEVELOPMENT SERVIC sonoma_ex1038.htm EX-10.38 16932
4 CERTIFICATION sonoma_ex3101.htm EX-31.1 8579
5 CERTIFICATION sonoma_ex3102.htm EX-31.2 8471
6 CERTIFICATION sonoma_ex3201.htm EX-32.1 4488
12 GRAPHIC image_001.jpg GRAPHIC 53238
  Complete submission text file 0001683168-23-007982.txt   3969597

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE snoa-20230930.xsd EX-101.SCH 28199
8 XBRL CALCULATION FILE snoa-20230930_cal.xml EX-101.CAL 47331
9 XBRL DEFINITION FILE snoa-20230930_def.xml EX-101.DEF 96092
10 XBRL LABEL FILE snoa-20230930_lab.xml EX-101.LAB 240070
11 XBRL PRESENTATION FILE snoa-20230930_pre.xml EX-101.PRE 197489
55 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-093023_htm.xml XML 475271
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 231398434
SIC: 2834 Pharmaceutical Preparations